ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

In Belief: Warren Ross Named Director Of Louisville’s Brown Cancer Center; NCI Landow Offices Moved

August 5, 1988

Sandra Swain at ASCO 2013: Let’s Focus on Three Goals

June 7, 2013

In Brief: Washington University, Barnes-Jewish to Combine Cancer Program In New Center

December 3, 1999

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

December 30, 2011

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997